← Open Payments lookup

RICHARD SCHLOSS: Open Payments

NPI 1992856660 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,109 in 115 payments from 18 companies in 2025. Trend: 2023 $4,251 · 2024 $2,897 · 2025 $3,109

Food & beverage: $3,109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$407
Axsome Therapeutics, Inc.13$393
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$372
Otsuka America Pharmaceutical, Inc.9$356
E.R. Squibb & Sons, L.L.C.4$258
ABBVIE INC.9$206
Janssen Pharmaceuticals, Inc8$180
Alkermes, Inc.9$169
Takeda Pharmaceuticals U.S.A., Inc.10$169
Lundbeck LLC13$152

Products named: REXULTI, INGREZZA, Auvelity, CAPLYTA, COBENFY, VRAYLAR, SPRAVATO, LYBALVI.

Industry payments across NY — which companies pay providers there.